109 related articles for article (PubMed ID: 38823222)
1. Evaluation of transport mechanisms of methotrexate in human choriocarcinoma cell lines by LC-MS/MS.
Bai M; Shen Q; Wu Y; Ma Z; Wang Y; Chen M; Liu D; Zhou L
J Pharm Biomed Anal; 2024 Sep; 247():116268. PubMed ID: 38823222
[TBL] [Abstract][Full Text] [Related]
2. Folate transporter dynamics and therapy with classic and tumor-targeted antifolates.
O'Connor C; Wallace-Povirk A; Ning C; Frühauf J; Tong N; Gangjee A; Matherly LH; Hou Z
Sci Rep; 2021 Mar; 11(1):6389. PubMed ID: 33737637
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma.
Jun F; Peng Z; Zhang Y; Shi D
Gynecol Oncol; 2020 Apr; 157(1):268-279. PubMed ID: 31955862
[TBL] [Abstract][Full Text] [Related]
4. Lectin galactoside-binding soluble 3 binding protein mediates methotrexate resistance in choriocarcinoma cell lines.
Chen X; Xue Y; Wang L; Weng Y; Li S; Lü W; Xie X; Cheng X
Bioengineered; 2022 Feb; 13(2):2076-2086. PubMed ID: 35038949
[TBL] [Abstract][Full Text] [Related]
5. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
Ikeda K; Yamasaki K; Homemoto M; Yamaue S; Ogawa M; Nakao E; Fukunaga Y; Nakanishi T; Utoguchi N; Myotoku M; Hirotani Y
Pharmazie; 2012 Jan; 67(1):86-90. PubMed ID: 22393837
[TBL] [Abstract][Full Text] [Related]
6. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
[TBL] [Abstract][Full Text] [Related]
7. Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference.
Ee PL; He X; Ross DD; Beck WT
Mol Cancer Ther; 2004 Dec; 3(12):1577-83. PubMed ID: 15634651
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
[TBL] [Abstract][Full Text] [Related]
10. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
[TBL] [Abstract][Full Text] [Related]
11. A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier.
Zhao R; Gao F; Hanscom M; Goldman ID
Clin Cancer Res; 2004 Jan; 10(2):718-27. PubMed ID: 14760095
[TBL] [Abstract][Full Text] [Related]
12. Comparison of folic acid uptake characteristics by human placental choriocarcinoma cells at acidic and physiological pH.
Keating E; Lemos C; Azevedo I; Martel F
Can J Physiol Pharmacol; 2006 Feb; 84(2):247-55. PubMed ID: 16900951
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP).
Markowicz-Piasecka M; Huttunen J; Montaser A; Adla SK; Auriola S; Lehtonen M; Huttunen KM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299347
[TBL] [Abstract][Full Text] [Related]
15. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
16. Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression.
Li H; Meng F; Jiang L; Ren Y; Qiu Z; Yu P; Peng J
Life Sci; 2019 Aug; 231():116548. PubMed ID: 31181228
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of antiepileptic drugs on folic acid uptake by human placental choriocarcinoma cells.
Kurosawa Y; Furugen A; Nishimura A; Narumi K; Kobayashi M; Iseki K
Toxicol In Vitro; 2018 Apr; 48():104-110. PubMed ID: 29223574
[TBL] [Abstract][Full Text] [Related]
18. Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats.
Shibayama Y; Ushinohama K; Ikeda R; Yoshikawa Y; Motoya T; Takeda Y; Yamada K
Cancer Sci; 2006 Nov; 97(11):1260-6. PubMed ID: 16925582
[TBL] [Abstract][Full Text] [Related]
19. Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.
Zamek-Gliszczynski MJ; Zhang X; Mudunuru J; Du Y; Chen JL; Taskar KS; Huang J; Huang Y; Romach EH
Drug Metab Dispos; 2019 Aug; 47(8):890-898. PubMed ID: 31167838
[TBL] [Abstract][Full Text] [Related]
20. [MTX sensitivity and the mechanism of resistance of various choriocarcinoma cells in culture].
Kaiho T; Sekiya S; Shirotake S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1611-6. PubMed ID: 6684670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
